Values as of: 2024-09-18
COMMON STOCK | Specialty Chemicals |
Last Closing
USD 121.07Change
+0.81 (+0.67)%Market Cap
USD 2.51BVolume
0.09MAnalyst Target
USD 62.00Verdict
Verdict
Hawkins, Inc. operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries. This segment manufactures sodium hypochlorite and agricultural products, as well as various food-grade and pharmaceutical products, such as liquid phosphates, lactates, other blended products, and agricultural products; and receives, stores, and distributes various chemicals comprising liquid caustic soda, sulfuric acid, hydrochloric acid, urea, phosphoric acid, aqua ammonia, and potassium hydroxide. It also repackages water treatment chemicals and bulk industrial chemicals; and performs custom blending of chemicals. The Water Treatment segment provides chemicals, products, equipment, services, and solutions for potable water, municipal and industrial wastewater, industrial process water, non-residential swimming pool water, and agriculture water. The Health and Nutrition segment offers ingredient distribution, processing, and formulation solutions to manufacturers of nutraceutical, functional food and beverage, personal care, dietary supplement and other nutritional food, and health and wellness products. Its products portfolio includes minerals, vitamins and amino acids, excipients, joint products, botanicals and herbs, sweeteners, and enzymes. Hawkins, Inc. was founded in 1938 and is headquartered in Roseville, Minnesota.
Company Website : https://www.hawkinsinc.com
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| LIN | Linde plc Ordinary Shares |
-4.63 (-0.98%) |
USD 223.86B |
| BCPC | Balchem Corporation |
+2.80 (+1.62%) |
USD 5.62B |
| WDFC | WD-40 Company |
+0.24 (+0.09%) |
USD 3.49B |
| IOSP | Innospec Inc |
-0.29 (-0.26%) |
USD 2.72B |
| HDSN | Hudson Technologies Inc |
-0.10 (-1.18%) |
USD 0.36B |
| LWLG | Lightwave Logic Inc |
+0.02 (+0.74%) |
USD 0.31B |
| GEVO | Gevo Inc |
-0.11 (-6.83%) |
USD 0.28B |
| ALTO | Alto Ingredients Inc |
+0.02 (+1.14%) |
USD 0.13B |
| NTIC | Northern Technologies |
-0.26 (-2.09%) |
USD 0.12B |
| LOOP | Loop Industries Inc |
-0.01 (-0.68%) |
USD 0.07B |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| FYC | First Trust Small Cap Gro.. | 0.76 % | 0.70 % |
+0.24 (+0.30%) |
USD 0.32B |
| RZG | Invesco S&P SmallCap 600.. | 0.00 % | 0.35 % |
+0.15 (+0.30%) |
N/A |
| Market Performance vs. Industry/Classification (Specialty Chemicals) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 71.93% | 100% | F | 93% | A | ||
| Dividend Return | 0.71% | 40% | F | 19% | F | ||
| Total Return | 72.64% | 100% | F | 93% | A | ||
| Trailing 12 Months | |||||||
| Capital Gain | 101.72% | 100% | F | 94% | A | ||
| Dividend Return | 1.10% | 33% | F | 17% | F | ||
| Total Return | 102.82% | 100% | F | 94% | A | ||
| Trailing 5 Years | |||||||
| Capital Gain | 459.21% | 91% | A- | 97% | N/A | ||
| Dividend Return | 12.77% | 100% | F | 53% | F | ||
| Total Return | 471.99% | 91% | A- | 97% | N/A | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 40.79% | 82% | B | 88% | B+ | ||
| Dividend Return | 42.45% | 82% | B | 88% | B+ | ||
| Total Return | 1.67% | 83% | B | 41% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 32.35% | 71% | C- | 58% | F | ||
| Risk Adjusted Return | 131.23% | 94% | A | 100% | F | ||
| Market Capitalization | 2.51B | 78% | C+ | 82% | B | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers median on a price to book value basis.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
